Alternatives to Vertice Pharma, LLC

International specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.

A leading global contract development and manufacturing organization (CDMO) for innovative biologic and small molecule therapies.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Develops a computational model of the human body for drug discovery and development.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Azurity Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing high-quality, affordable liquid medications.

Physics-based software platform for molecular discovery and design in life and materials sciences.

Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.

AI company using federated learning to solve biological complexity and accelerate drug discovery.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

A global oncology company developing and commercializing innovative cancer treatments.

Advancing next-generation mRNA medicines.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Immunotherapy company targeting oncology and autoimmune diseases.

AI-powered research assistant for scientific literature review and data extraction.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing highly targeted, small molecule medicines.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A biotechnology company focused on oncology drug discovery.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing genetic therapies for rare disorders.

Biotechnology company developing novel therapeutics by harnessing the autophagy pathway to treat serious diseases.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Robotic avatars and AI agents for pharmaceutical and medical cleanrooms to eliminate human contamination.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Pioneering vision restoration therapies for severe retinal degenerations.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

AI-powered antibody discovery platform.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

AI platform for engineering molecular glues to create a new class of medicines.

Developing novel Alphamer® therapeutics to combat serious diseases, with a primary focus on antimicrobial resistance (AMR).

Developing first-in-class oral therapy for BK polyomavirus infections.

Global immunology company developing antibody-based therapies for severe autoimmune diseases.

Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Developing novel male contraceptives.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.